Mitry Ragai R, Dhawan Anil, Hughes Robin D, Bansal Sanjay, Lehec Sharon, Terry Claire, Heaton Nigel D, Karani John B, Mieli-Vergani Giorgina, Rela Mohamed
Institute of Liver Studies, Guy's, King's and St. Thomas' School of Medicine, and King's College Hospital, Denmark Hill, London, United Kingdom.
Transplantation. 2004 May 27;77(10):1614-6. doi: 10.1097/01.tp.0000122224.98318.19.
Hepatocyte transplantation is emerging as a possible treatment for patients with acute liver failure and liver-based metabolic disorders. With the limited availability of donor tissue, it is important to find new sources of liver tissue for isolation of high-quality hepatocytes. Segment IV with or without the caudate lobe was removed during three split-liver procedures. Hepatocytes were isolated from the tissues using a collagenase perfusion technique under strict sterile conditions. The mean number of hepatocytes that were isolated was 5.14 x 10(8) cells with a mean cell viability of 89%. Two of the hepatocyte preparations were used for cell transplantation in a 1-day-old boy with an antenatal diagnosis of a severe urea cycle defect caused by ornithine transcarbamylase deficiency. The six recipients of split-liver grafts demonstrated no complications related to the removal of segment IV. Segment IV with or without the caudate lobe obtained from split-liver procedures is potentially a good source of high-quality hepatocytes for cell transplantation.
肝细胞移植正逐渐成为治疗急性肝衰竭和肝脏代谢紊乱患者的一种可能方法。鉴于供体组织的可用性有限,寻找新的肝脏组织来源以分离高质量的肝细胞至关重要。在三次活体肝移植手术中切除了含或不含尾状叶的IV段。在严格的无菌条件下,使用胶原酶灌注技术从组织中分离肝细胞。分离出的肝细胞平均数量为5.14×10⁸个细胞,平均细胞活力为89%。两份肝细胞制剂被用于一名1日龄男婴的细胞移植,该男婴产前诊断为因鸟氨酸转氨甲酰酶缺乏导致的严重尿素循环缺陷。六名活体肝移植受者未出现与切除IV段相关的并发症。从活体肝移植手术中获得的含或不含尾状叶的IV段可能是用于细胞移植的高质量肝细胞的良好来源。